Physician profile
Ryan Miller
NPI 1366882615
$5,054.38
in general payments reported to CMS, 2019-2025
5 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $16.24 · 2024: $4,550 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,550 · Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,550.00 |
| Food and Beverage | $360.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $4,550.00 | 2024 | Cabenuva |
| Gilead Sciences, INC. | $218.17 | 2025 | Biktarvy |
| Abbvie INC. | $142.70 | 2025 | |
| Insmed, INC. | $103.52 | 2019-2020 | |
| Astellas Pharma US INC | $39.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.